Full house: 900 cluster professionals and policy makers in Brussels at the European Cluster Conference in Brussels, © ECCP.2024

More than 900 experts from clusters and the EU Commission discussed at the sold-out 9th European Cluster Conference what cluster policy is needed to make Europe a world leader in prioritised technology fields  such as the green and digital transitions and biotechnology.

From left to right: Thomas Schmidt, co-founder and CEO at 21st.BIO, Margrethe Vestager, Executive Vice President of the European Commia hundred other guests from the financial, political, and bio industrial sectors.ssion, and Per Falholt, co-founder and CSO at 21st.BIO, unveiled 21st.BIO’s pilot plant facility. © 21st.BIO A/S

Danish CDMO 21st.BIO A/S has unveiled a new pilot plant facility to accelerate scaling of biotech processes ranging from food and beverages, agriculture, biomaterials, and biopharma.
  

  

© German cancer research centre/ University Heidelberg

Flagging of CAR-T cells with the B7H6 protein weakened the response to human leukaemia in models as it marks them for NK cell attack, German researchers report.

Platform of Biotalys. © Biotalys BV

Belgian AgTech specialist Biotalys BV an Agricultural Technology (AgTech) company has initiated field trials for BioFun-6, the company’s second llama-antibody-mimicking biofungicide program.

Fundus of patient with teinitis pigmentosa. © By Christian Hamel - wikimedia.org

AI specialist WhiteLab Genomics, the Vision Institute, and IT expert ADLIN Science, have entered into a strategic partnership aimed at developing new AAV vectors targetting retinal dystrophies.

© University of Southern Denmark

A German-Danish team has discovered that a truncated version of the enzyme adenlyate cyclase 3 can be targeted to transform fat-storing white adipocytes into fat-burning brown adipocytes.

Klineo team has grown since its inception in 2021. © Kineo SAS

Paris-based Klineo SAS has raised €2M to speed up access to clinical trials for oncology patients using an AI platform.
`

LG Draft "ball". © Locate Bio Ltd

University Nottingham spin out Locate Bio Ltd has added £9.2m venture financing led by Mercia Ventures and Business Growth Fund to its £16.2m raised before.

Electrochaea‘s scalable methanation system. © Electrochea GmbH

Archaeal Power-to-biomethan producer Electrochaea GmbH has sold a BioCat bioreactor to the Danish CCU  specialist Again A/S.

Structuren of Pub domain of RNF31. © RCBS protein data base

Oss-based oncology company Flindr Therapeutics BV has secured €20m  to advance it first-in-class RNF31 inhibitors, which destabilises E3 ubiquitin ligase.